Sign up to save your podcasts
Or
Share The Kingfisher Trial of Brolucizumab for DME
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
The Kingfisher Trial of Brolucizumab for DME
We discuss the results of the Kingfisher trail, a study employing broluizumab q4 weeks for the treatment of diabetic macular edema with Dr. Mark Barakat, Assistant Clinical Profess of Ophthalmology, University of Arizona College of Medicine Phoenix.
View all episodes
By Retina Synthesis
4.5
88 ratings
We discuss the results of the Kingfisher trail, a study employing broluizumab q4 weeks for the treatment of diabetic macular edema with Dr. Mark Barakat, Assistant Clinical Profess of Ophthalmology, University of Arizona College of Medicine Phoenix.
More shows like Retina Synthesis
View all
New Retina Radio by Eyetube
18 Listeners
White Coat Investor Podcast
2,445 Listeners
The Daily
112,683 Listeners
WSJ Minute Briefing
673 Listeners
Up First from NPR
56,469 Listeners
Bogleheads On Investing Podcast
595 Listeners
MedEdTalks - Ophthalmology
4 Listeners
American Journal of Ophthalmology Podcasts Collection
11 Listeners
Experts InSight
52 Listeners
RETINA Journal Podcasts
10 Listeners
Ophthalmology Journal
18 Listeners
Talking Euretina
1 Listeners
RetinaRounds™
0 Listeners
The Last Invention
708 Listeners